1
|
Bikash C, Sarkar R. Topical management of acne scars: The uncharted terrain. J Cosmet Dermatol 2023; 22:1191-1196. [PMID: 36606377 DOI: 10.1111/jocd.15584] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2022] [Revised: 12/02/2022] [Accepted: 12/11/2022] [Indexed: 01/07/2023]
Abstract
INTRODUCTION Scarring is a common but difficult to manage consequence of acne vulgaris. The intricate balance between the degradation of collagen and its inhibition is disturbed during the formation of acne scars. We mostly rely on invasive, non-topical modalities for the treatment of acne scars which may not be indicated in all patients. There is also a need for maintainence therapies after these procedures. REVIEW The topical agents can be utilized as individual therapy, in combination with other modalities or delivered through assisted technology like iontophoresis. Retinoids have long been tried to prevent and treat acne scars. Tacrolimus and glycolic acid are among the newer sole agents that have been explored. Ablative lasers like Er:YAG, CO2 and Microneedling are being used in combination with topical agents like silicone gel, plasma gel, lyophilized growth factors, platelet rich plasma, insulin, and mesenchymal stem cells. These procedures not only increase the permeability of the topical agents but also concomitantly improve acne scars. Iontophoresis has proven beneficial in increasing the delivery of topical estriol and tretinoin. CONCLUSION There is lack of evidence to support the widespread use of these topical agents, and therefore, there is need for further well designed studies.
Collapse
Affiliation(s)
- Chingshubam Bikash
- Department of Dermatology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Meghalaya, India
| | - Rashmi Sarkar
- Department of Dermatology, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India
| |
Collapse
|
2
|
Liatsopoulou A, Varvaresou A, Mellou F, Protopapa E. Iontophoresis in dermal delivery: A review of applications in dermato-cosmetic and aesthetic sciences. Int J Cosmet Sci 2022; 45:117-132. [PMID: 36326063 DOI: 10.1111/ics.12824] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2022] [Revised: 09/30/2022] [Accepted: 10/14/2022] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Iontophoresis is defined as the use of electric current to drive molecules across cell membranes through an electrolyte solution. In therapeutic context, it is used to facilitate the administration of bioactive substances, either systemically or locally. The technique presents various advantages and that is why it has been successfully used by a plethora of medical sciences. The constantly developing field of dermato-cosmetic science has also taken advantage of the possibilities offered by iontophoresis, aiming to enhance the delivery of the applied active ingredients and, thus, induce the desired cosmetic effects. METHODS The available literature was examined for evidence-based reports of safe and successful iontophoresis of pharmaceutical and cosmetic substances, in order to explore different iontophoretic applications in the field of dermato-cosmetic and dermato-aesthetic sciences. CONCLUSION Iontophoresis can be safely and successfully used in the treatment of ageing, photoageing, hyperpigmentation, oxidative stress, hair loss, hair removal, acne, acne sequelae and cellulite, providing many possibilities for enhanced treatment results.
Collapse
Affiliation(s)
- Aikaterini Liatsopoulou
- Laboratory of Chemistry, Biochemistry and Cosmetic Science, Division of Aesthetics and Cosmetic Science, Department of Biomedical Sciences, School of Health and Caring Sciences, University of West Attica, Athens, Greece
| | - Athanasia Varvaresou
- Laboratory of Chemistry, Biochemistry and Cosmetic Science, Division of Aesthetics and Cosmetic Science, Department of Biomedical Sciences, School of Health and Caring Sciences, University of West Attica, Athens, Greece
| | - Fotini Mellou
- Laboratory of Chemistry, Biochemistry and Cosmetic Science, Division of Aesthetics and Cosmetic Science, Department of Biomedical Sciences, School of Health and Caring Sciences, University of West Attica, Athens, Greece
| | - Evangelia Protopapa
- Laboratory of Chemistry, Biochemistry and Cosmetic Science, Division of Aesthetics and Cosmetic Science, Department of Biomedical Sciences, School of Health and Caring Sciences, University of West Attica, Athens, Greece
| |
Collapse
|
3
|
Akhtar N, Singh V, Yusuf M, Khan RA. Non-invasive drug delivery technology: development and current status of transdermal drug delivery devices, techniques and biomedical applications. ACTA ACUST UNITED AC 2020; 65:243-272. [PMID: 31926064 DOI: 10.1515/bmt-2019-0019] [Citation(s) in RCA: 62] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2019] [Accepted: 08/30/2019] [Indexed: 12/25/2022]
Abstract
Pay-load deliveries across the skin barrier to the systemic circulation have been one of the most challenging delivery options. Necessitated requirements of the skin and facilitated skin layer cross-over delivery attempts have resulted in development of different non-invasive, non-oral methods, devices and systems which have been standardized, concurrently used and are in continuous upgrade and improvements. Iontophoresis, electroporation, sonophoresis, magnetophoresis, dermal patches, nanocarriers, needled and needle-less shots, and injectors are among some of the methods of transdermal delivery. The current review covers the current state of the art, merits and shortcomings of the systems, devices and transdermal delivery patches, including drugs' and other payloads' passage facilitation techniques, permeation and absorption feasibility studies, as well as physicochemical properties affecting the delivery through different transdermal modes along with examples of drugs, vaccines, genes and other payloads.
Collapse
Affiliation(s)
- Naseem Akhtar
- Department of Pharmaceutics, College of Pharmacy,Buraydah Colleges, PO Box 31717, Qassim 51418, Saudi Arabia
| | - Varsha Singh
- Manav Rachna International University (MRIU) and Manav Rachna International Institute of Research and Study (MRIIRS), Faridabad, HR 121 001, India
| | - Mohammad Yusuf
- College of Pharmacy, University of Taif, Taif Al-Haweiah, Taif, Saudi Arabia.https://orcid.org/0000-0003- 1417-7774
| | - Riaz A Khan
- Manav Rachna International University (MRIU) and Manav Rachna International Institute of Research and Study (MRIIRS), Faridabad, HR 121 001, India.,Department of Medicinal Chemistry, College of Pharmacy, Qassim University, Qassim 51452, Saudi Arabia
| |
Collapse
|
4
|
Abstract
Background: The application of therapeutic agents to the skin addresses three general objectives: (a) the treatment of a variety of dermatologic diseases; (b) the “targeted” delivery of drugs to deeper subcutaneous tissues, with a concomitant reduction in systemic exposure; and (c) socalled transdermal administration to elicit a systemic pharmacologic effect. Objective: Recently, significant progress towards all three goals has been recorded and the level of research and development activity remains high. We aim to discuss these advances from mechanistic and clinical standpoints. Results: For the topical treatment of skin disease, novel vehicles (e.g., stabilized, supersaturated systems and liposomal formulations) have led to dramatic improvements in local drug bioavailability. Transdermal delivery of drugs for systemic effect, though limited in terms of the number of compounds, is perhaps the most commercially successful (in terms of the number of products) of the controlled release technologies. Considerable activity continues to enhance drug delivery (and hence to extend the range of drugs for which transdermal delivery can be used). Existing patches use formulations that contain solvents and adjuvants capable of reducing the barrier function of the skin. Much effort is directed at iontophoresis (electrically enhanced transport), particularly for small peptides that are difficult to administer by other routes. “Reverse iontophoresis” may allow the extraction of glucose (without skin puncture) so that continuous, noninvasive monitoring of blood sugar in diabetics approaches realization. Conclusion: In the not too distant future, the skin may also play a role not only in drug delivery, but also with respect to measurements in clinical chemistry.
Collapse
Affiliation(s)
- Virginia Merino
- Centre Interuniversitaire de Recherche et d'Enseignement, “Pharmapeptides,” Campus Universitaire, Parc d'Affaires International, Archamps, France
- Departamento de Farmacia y Tecnologia Farmaceutica. Facultad de Farmacia, Universidad de Valencia. Burjassot, Valencia, Spain
| | - Ingo Alberti
- Centre Interuniversitaire de Recherche et d'Enseignement, “Pharmapeptides,” Campus Universitaire, Parc d'Affaires International, Archamps, France
- Faculté des Sciences — Section Pharmacie, Laboratoire de Pharmacie Galénique, Université de Genève, Genève, Switzerland
| | - Yogeshvar N. Kalia
- Centre Interuniversitaire de Recherche et d'Enseignement, “Pharmapeptides,” Campus Universitaire, Parc d'Affaires International, Archamps, France
- Faculté des Sciences — Section Pharmacie, Laboratoire de Pharmacie Galénique, Université de Genève, Genève, Switzerland
| | - Richard H. Guy
- Centre Interuniversitaire de Recherche et d'Enseignement, “Pharmapeptides,” Campus Universitaire, Parc d'Affaires International, Archamps, France
- Faculté des Sciences — Section Pharmacie, Laboratoire de Pharmacie Galénique, Université de Genève, Genève, Switzerland
| |
Collapse
|
5
|
Levy LL, Zeichner JA. Management of acne scarring, part II: a comparative review of non-laser-based, minimally invasive approaches. Am J Clin Dermatol 2012; 13:331-40. [PMID: 22849351 DOI: 10.2165/11631410-000000000-00000] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Acne scarring is a commonly encountered yet extremely challenging problem to treat for the dermatologist. As acne scarring can lead to significant psychological distress and low self-esteem, it is of utmost importance to have effective and satisfying treatments in the physician's armamentarium. However, many treatments are unsatisfying, leading to patient disappointment and frustration. Although early treatment of acne lesions and inflammation with isotretinoin is beneficial in preventing acne scarring, many patients still present with troubling noticeable scars. Despite the advances in pharmacology and technology, scar treatment still remains suboptimal and is tainted with several adverse effects. However, some treatments can provide benefits. This review article exhaustively discusses and analyzes the various minimally invasive approaches to the treatment of acne scarring with an emphasis on pharmacologic agents, such as isotretinoin for atrophic acne scars and corticosteroids and chemotherapeutic drugs for hypertrophic scars. Intralesional injections of corticosteroids are efficacious in reducing keloid scar formation in addition to preventing recurrence following surgical excision. In-office and minimally invasive procedural management, including chemical peels, dermabrasion, tissue augmentation, and punch excision is also discussed. Superficial chemical peels are efficacious in treating atrophic scars with relatively few adverse effects and complications. Although dermabrasion is used less often with the advent of laser resurfacing, this technique remains as a viable option for those with atrophic scars. Post-inflammatory hyperpigmentation can be managed successfully with topical agents such as azelaic acid and hydroquinone. The efficacy of various treatment modalities is highlighted with a focus on choosing the correct modalities for specific scar types.
Collapse
|
6
|
Rawat S, Vengurlekar S, Rakesh B, Jain S, Srikarti G. Transdermal delivery by iontophoresis. Indian J Pharm Sci 2011; 70:5-10. [PMID: 20390073 PMCID: PMC2852061 DOI: 10.4103/0250-474x.40324] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2006] [Revised: 10/26/2007] [Accepted: 01/04/2008] [Indexed: 11/05/2022] Open
Abstract
Recently there has been an increased interest in using iontophoretic technique for the transdermal delivery of medications, both ionic and nonionic. This article is an overview of the history of iontophoresis and factors affecting iontophoretic drug transfer for the systemic effects and laws for development of Transdermal delivery system are discussed.
Collapse
Affiliation(s)
- Swati Rawat
- Smriti College of Pharmaceutical Education, Indore - 452 010, India
| | | | | | | | | |
Collapse
|
7
|
Escobar-Chávez JJ, Merino V, Díez-Sales O, Nácher-Alonso A, Ganem-Quintanar A, Herráez M, Merino-Sanjuán M. Transdermal nortriptyline hydrocloride patch formulated within a chitosan matrix intended to be used for smoking cessation. Pharm Dev Technol 2010; 16:162-9. [DOI: 10.3109/10837450903584902] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
8
|
Abstract
World consumers are nowadays more focused on their health and appearance. This trend is creating heightened demand for products formulated with natural and nutraceutical ingredients. Functional ingredients and innovative delivery systems are driving the new product development in the field of cosmetics. A significant number of innovative formulations are now being used in personal care with real consumer-perceivable benefits and optimized sensory attributes, resulting in an economic uplift of cosmetic industry. In fact, the U.S. market alone for novel cosmetic delivery systems has been projected to be more than $41 billion for the year 2007. Novel cosmetic delivery systems reviewed here possess enormous potential as next-generation smarter carrier systems.
Collapse
Affiliation(s)
- V B Patravale
- Department of Pharmaceutical Sciences and Technology, University Institute of Chemical Technology, Mumbai 400 019, India.
| | | |
Collapse
|
9
|
Fernandes D. Minimally Invasive Percutaneous Collagen Induction. Oral Maxillofac Surg Clin North Am 2005; 17:51-63, vi. [DOI: 10.1016/j.coms.2004.09.004] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
10
|
Abstract
The skin is one of the largest organs of the body, which is significantly affected by the aging process and menopause. The significant changes sustained by the skin during the menopause are due to the effect sustained on the skin's individual components. The estrogen receptor has been detected on the cellular components of the skin. Accordingly, dermal cellular metabolism is influenced by the hypoestrogenoemic state of menopause leading to changes in the collagen content, alterations in the concentration of glycoaminoglycans and most importantly the water content. Consequently changes in these basic components leads to an alteration in function compatible with skin aging. Changes in the skin collagen leads to diminished elasticity and skin strength. Collagen content may be measured by various methods such as direct skin biopsy, skin blister assessment for collagen markers and skin thickness measurement. All these variables indicate a reduction in collagen content following menopause. This may be reversed with the administration of estrogen given both topically and systemically.A reduction in hydrophilic glycoaminglycans leads to a direct reduction in water content, which influences the skin turgor. These effects on glycoaminoglycans, due to the hypoestrogenia, have been clearly shown in animal studies and appeared to be rapidly reversed with the application of estrogens. The sum total of these basic effects on the skin leads to wrinkles, the skin condition typifying skin aging.Structures resident in the skin are likewise influenced by menopause. Changes to the cutaneous vascular reactivity are noted following menopause. Capillary blood flow velocity decreases significantly in postmenopausal women. Postmenopausal flushing is due to profound vasodilatation in the dermal papillae. Hair growth is also influenced by the hormonal milieu and consequently hair loss has been associated with the beginning of menopause. Treatments administered for menopause, in particular hormone replacement therapy, appear to alter its effects on the basic components of the skin as well as the more complex structures residing in the skin, consequently retarding the skin aging process.
Collapse
|
11
|
Abstract
Estrogens have a profound influence on skin. The hypoestrogenism occurring after the menopause leads to measured deterioration in the skin. Estrogen receptors have been identified in the skin and the concentration of these receptors varies in the different parts of the body. Estrogen improves skin in more than one way, the collagen content and quality is improved, skin thickness is increased, while vascularisation is enhanced. The extracellular matrix responsible for the tone and appearance of the skin is also improved. It is not just the skin that shows an improvement with estrogen therapy but also skin appendages, such as hair. Estrogens have been shown to increase the hair follicle life cycle. Skin aging is not totally estrogen dependent because the ravages of age and the external environment play very important roles. The effects of estrogen on skin need further elucidation and with the emergence of newer techniques it is now possible to study more clearly the changes occurring at the cellular level. Estrogen replacement reverses the deleterious effect of estrogen deprivation on the skin, which is thus yet another organ that benefits from hormone replacement therapy.
Collapse
Affiliation(s)
- M P Brincat
- School of Human Development, Queens Medical Centre, University of Nottingham, Nottingham, UK
| |
Collapse
|
12
|
Abstract
BACKGROUND Atrophic acne scars are a frequent problem after acne. Hitherto, mainly invasive treatment measures were possible. In a recent paper, we demonstrated the positive effects of iontophoresis with 0.025% tretinoin gel vs. estriol 0.03%. OBJECTIVE In this further study, the recording of the clinical effects of iontophoresis with 0.025% tretinoin gel in atrophic acne scars was supplemented by immunohistochemistry investigations of collagen I and III, proliferation markers, and the estimation of epidermal thickness. METHODS The treatment was performed twice weekly in 32 volunteer patients for a period of 3 months by application of the substance under a constant direct current of 3 mA for 20 min. Skin biopsies prior to and at the end of treatment were performed in 32 voluntary patients in order to investigate collagen I/III and proliferation markers by immunohistochemistry methods. RESULTS Clinically, at the end of treatment, in 94% of patients a significant decrease in the scar depth was observed. Neither epidermal thickness nor proliferation markers revealed a significant increase at the end of treatment. Furthermore, collagen I and collagen III showed no common trend, as expressed statistically by a lack of significance. In some cases, increases in collagen III became evident at the end of treatment. CONCLUSIONS Tretinoin-iontophoresis is an effective, noninvasive treatment of atrophic acne scars without causing disturbing side-effects.
Collapse
Affiliation(s)
- J B Schmidt
- Department of Dermatology, Institute of Clinical Pathology, University of Vienna Medical School, Austria
| | | | | | | | | | | |
Collapse
|
13
|
Abstract
Acne is one of the most common and easily treated diseases of adolescents. Scarring can be prevented in most cases with early and vigorous treatment. But such treatment requires patience, skill, and a commitment to good counseling.
Collapse
Affiliation(s)
- V C Strasburger
- Department of Pediatrics, University of New Mexico School of Medicine, Albuquerque, USA
| |
Collapse
|
14
|
Abstract
Iontophoresis, the use of an electric current to drive charged molecules across the skin, has the potential to expand the feasible range of drugs for transdermal administration significantly. This method of delivery is being examined carefully with respect to higher-molecular-weight therapeutics (in particular, peptides and small proteins), which cannot be absorbed following oral administration and for which, at this time, an invasive injection remains the only option. In addition, the procedure of so-called 'reverse' iontophoresis would appear to represent a truly noninvasive approach for diagnostic monitoring of blood chemistry.
Collapse
Affiliation(s)
- V Merino
- Centre Interuniversitaire de Recherche et d'Enseignement, Pharmapeptides, Parc d'Affaires International, Archamps, France
| | | | | |
Collapse
|
15
|
Abstract
BACKGROUND The coincidence of climacteric symptoms and the beginning of skin aging suggests that estrogen deficiency may be a common and important factor in the perimenopausal woman. Often hormones have been considered important in endogenous aging of the skin, but their role has not been clearly defined. Therefore, we investigated, whether topical treatment of the skin with estrogen could reverse some of the changes in the aging skin. MATERIAL AND METHODS The effects of 0.01% estradiol and 0.3% estriol compounds were compared in 59 preclimacteric women with skim aging symptoms. Monthly determinations of estrodiol (E2), follicle-stimulating hormone (FSH), and prolactin (PRL) were done and the monthly clinical monitoring was supplemented by measurements of skin hydration by corneometry and profilometry. In 10 patients, skin biopsies were taken for immunohistochemical determination of collagen types I and III. RESULTS After treatment for 6 months, elasticity and firmness of the skin had markedly improved and the wrinkle depth and pore sizes had decreased by 61 to 100% in both groups. Furthermore, skin moisture had increased and the measurement of wrinkles using skin profilometry, revealed significant, or even highly significant, decreases of wrinkle depth in the estradiol and the estriol groups, respectively. On immunohistochemistry, significant increases of Type III collagen labeling were combined with increased numbers of collagen fibers at the end of the treatment period. As to hormone levels, only those of PRL had increased significantly and no systemic hormonal side effects were noted.
Collapse
Affiliation(s)
- J B Schmidt
- Department of Dermatology, University of Vienna Medical School, Austria
| | | | | | | | | |
Collapse
|